SPATA20
gene geneOn this page
Also known as FLJ21347SSP411Tisp78
Summary
SPATA20 (spermatogenesis associated 20, HGNC:26125) is a protein-coding gene on chromosome 17q21.33, encoding Spermatogenesis-associated protein 20 (Q8TB22). May play a role in fertility regulation.
Predicted to be involved in carbohydrate metabolic process; cell differentiation; and spermatogenesis. Located in mitochondrion.
Source: NCBI Gene 64847 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 161 total
- MANE Select transcript:
NM_022827
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26125 |
| Approved symbol | SPATA20 |
| Name | spermatogenesis associated 20 |
| Location | 17q21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21347, SSP411, Tisp78 |
| Ensembl gene | ENSG00000006282 |
| Ensembl biotype | protein_coding |
| OMIM | 613939 |
| Entrez | 64847 |
Gene structure
Transcript identifiers
Ensembl transcripts: 44 — 20 protein_coding, 14 retained_intron, 10 nonsense_mediated_decay
ENST00000006658, ENST00000356488, ENST00000502911, ENST00000503063, ENST00000503127, ENST00000504265, ENST00000504271, ENST00000504334, ENST00000505085, ENST00000505336, ENST00000505456, ENST00000505559, ENST00000505656, ENST00000508528, ENST00000508598, ENST00000510917, ENST00000511347, ENST00000511605, ENST00000511845, ENST00000511937, ENST00000512181, ENST00000512416, ENST00000513618, ENST00000515526, ENST00000515619, ENST00000634597, ENST00000635113, ENST00000860309, ENST00000860310, ENST00000860311, ENST00000860312, ENST00000860313, ENST00000860314, ENST00000860315, ENST00000860316, ENST00000860317, ENST00000860318, ENST00000860319, ENST00000860320, ENST00000912606, ENST00000953007, ENST00000953008, ENST00000953009, ENST00000953010
RefSeq mRNA: 3 — MANE Select: NM_022827
NM_001258372, NM_001258373, NM_022827
CCDS: CCDS11571, CCDS58563
Canonical transcript exons
ENST00000006658 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002083643 | 50547174 | 50547285 |
| ENSE00003458621 | 50550536 | 50550610 |
| ENSE00003465853 | 50548283 | 50548453 |
| ENSE00003475153 | 50549043 | 50549186 |
| ENSE00003496489 | 50548554 | 50548618 |
| ENSE00003516663 | 50550708 | 50550917 |
| ENSE00003533479 | 50547720 | 50547767 |
| ENSE00003538569 | 50554251 | 50554450 |
| ENSE00003548869 | 50548810 | 50548964 |
| ENSE00003574046 | 50550998 | 50551190 |
| ENSE00003595700 | 50555492 | 50555852 |
| ENSE00003597185 | 50550208 | 50550312 |
| ENSE00003598717 | 50551969 | 50552180 |
| ENSE00003640118 | 50549286 | 50549487 |
| ENSE00003663425 | 50549985 | 50550115 |
| ENSE00003665752 | 50555232 | 50555312 |
| ENSE00003672833 | 50551511 | 50551679 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 98.42.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 40.5836 / max 228.2490, expressed in 1789 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 161683 | 40.3925 | 1789 |
| 161684 | 0.1220 | 5 |
| 161686 | 0.0536 | 4 |
| 161685 | 0.0155 | 3 |
Top tissues by expression
291 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.42 | gold quality |
| right testis | UBERON:0004534 | 98.35 | gold quality |
| apex of heart | UBERON:0002098 | 97.11 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.87 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.80 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.76 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 96.73 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.72 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.68 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.52 | gold quality |
| thyroid gland | UBERON:0002046 | 96.48 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.26 | gold quality |
| testis | UBERON:0000473 | 96.03 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.96 | gold quality |
| left ovary | UBERON:0002119 | 95.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 95.66 | gold quality |
| cerebellar cortex | UBERON:0002129 | 95.63 | gold quality |
| adrenal gland | UBERON:0002369 | 95.53 | gold quality |
| right ovary | UBERON:0002118 | 95.47 | gold quality |
| male germ cell | CL:0000015 | 95.31 | gold quality |
| body of stomach | UBERON:0001161 | 95.13 | gold quality |
| sperm | CL:0000019 | 95.11 | gold quality |
| cerebellum | UBERON:0002037 | 94.83 | gold quality |
| endocervix | UBERON:0000458 | 94.71 | gold quality |
| cardia of stomach | UBERON:0001162 | 94.58 | gold quality |
| transverse colon | UBERON:0001157 | 94.43 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 94.29 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.24 | gold quality |
| fundus of stomach | UBERON:0001160 | 94.16 | gold quality |
| body of pancreas | UBERON:0001150 | 94.10 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting SPATA20, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-6765-3P | 97.83 | 64.59 | 1165 |
Literature-anchored findings (GeneRIF, showing 2)
- SSP411 has potential as a biomarker for the diagnosis of Cholangiocarcinoma (PMID:23118872)
- Identification of nonfunctional SPATA20 causing acephalic spermatozoa syndrome in humans. (PMID:36415156)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spata20 | ENSDARG00000013880 |
| mus_musculus | Spata20 | ENSMUSG00000020867 |
| rattus_norvegicus | Spata20 | ENSRNOG00000003273 |
| drosophila_melanogaster | CG8613 | FBGN0033924 |
| caenorhabditis_elegans | WBGENE00015204 |
Protein
Protein identifiers
Spermatogenesis-associated protein 20 — Q8TB22 (reviewed: Q8TB22)
Alternative names: Sperm-specific protein 411
All UniProt accessions (7): Q8TB22, A0A0U1RRL8, D6R947, D6RC70, D6RIU6, H0Y9M1, H0Y9W3
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in fertility regulation.
Subcellular location. Secreted.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TB22-1 | 1 | yes |
| Q8TB22-2 | 2 | |
| Q8TB22-3 | 3 | |
| Q8TB22-4 | 4 |
RefSeq proteins (3): NP_001245301, NP_001245302, NP_073738* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004879 | Ssp411-like_TRX | Domain |
| IPR008928 | 6-hairpin_glycosidase_sf | Homologous_superfamily |
| IPR012341 | 6hp_glycosidase-like_sf | Homologous_superfamily |
| IPR024705 | Ssp411 | Family |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
Pfam: PF03190
UniProt features (14 total): splice variant 5, sequence variant 3, sequence conflict 2, signal peptide 1, chain 1, region of interest 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TB22-F1 | 90.38 | 0.81 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 649
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
FXR_IR1_Q6, TGACCTY_ERR1_Q2, GOBP_MALE_GAMETE_GENERATION, YGACNNYACAR_UNKNOWN, ONKEN_UVEAL_MELANOMA_UP, ATF1_Q6, MODULE_301, GOBP_CARBOHYDRATE_METABOLIC_PROCESS, BASAKI_YBX1_TARGETS_DN, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, DR3_Q4, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, MARTENS_TRETINOIN_RESPONSE_UP, VDR_Q6
GO Biological Process (3): carbohydrate metabolic process (GO:0005975), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (2): extracellular region (GO:0005576), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| primary metabolic process | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
704 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA20 | SPATA6 | Q9NWH7 | 595 |
| SPATA20 | SPATA4 | Q8NEY3 | 532 |
| SPATA20 | SPATA46 | Q5T0L3 | 527 |
| SPATA20 | PUSL1 | Q8N0Z8 | 496 |
| SPATA20 | SPATA17 | Q96L03 | 489 |
| SPATA20 | SPATA3 | Q8NHX4 | 458 |
| SPATA20 | SPATA22 | Q8NHS9 | 455 |
| SPATA20 | SPATA25 | Q9BR10 | 451 |
| SPATA20 | CROCC2 | H7BZ55 | 443 |
| SPATA20 | SPATA7 | Q9P0W8 | 432 |
| SPATA20 | CFAP184 | Q2M329 | 416 |
| SPATA20 | HEATR9 | A2RTY3 | 410 |
| SPATA20 | IQCN | Q9H0B3 | 403 |
| SPATA20 | COASY | Q13057 | 395 |
| SPATA20 | AFG2A | Q8NB90 | 378 |
IntAct
42 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TADA3 | TADA2A | psi-mi:“MI:0914”(association) | 0.740 |
| ETFRF1 | NDUFAB1 | psi-mi:“MI:0914”(association) | 0.640 |
| COX5B | COX7A2L | psi-mi:“MI:0914”(association) | 0.530 |
| NIPSNAP3A | CLUH | psi-mi:“MI:0914”(association) | 0.530 |
| COLGALT2 | COL1A1 | psi-mi:“MI:0914”(association) | 0.530 |
| CCL5 | C4A | psi-mi:“MI:0914”(association) | 0.530 |
| ODF1 | TCP1 | psi-mi:“MI:0914”(association) | 0.530 |
| GPSM3 | ATE1 | psi-mi:“MI:0914”(association) | 0.530 |
| LYG2 | TRAF2 | psi-mi:“MI:0914”(association) | 0.530 |
| UQCRFS1 | NDUFAB1 | psi-mi:“MI:0914”(association) | 0.530 |
| SPATA20 | MYBPC3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| CORO1A | SPATA20 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPATA20 | ST6GALNAC4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SPATA20 | PMPCB | psi-mi:“MI:0914”(association) | 0.350 |
| TRUB2 | NME6 | psi-mi:“MI:0914”(association) | 0.350 |
| TRUB2 | SPATA20 | psi-mi:“MI:0914”(association) | 0.350 |
| SPATA20 | NDUFAB1 | psi-mi:“MI:0914”(association) | 0.350 |
| MICOS13 | MTX2 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFV3 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFA10 | AURKA | psi-mi:“MI:0914”(association) | 0.350 |
| LYG2 | PLOD3 | psi-mi:“MI:0914”(association) | 0.350 |
| HS1BP3 | TAF5L | psi-mi:“MI:0914”(association) | 0.350 |
| RAB20 | BCL10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (76): SPATA20 (Affinity Capture-MS), SPATA20 (Affinity Capture-MS), SPATA20 (Affinity Capture-MS), AGL (Co-fractionation), SPATA20 (Affinity Capture-MS), SPATA20 (Affinity Capture-MS), NUDT8 (Affinity Capture-MS), LYRM7 (Affinity Capture-MS), GLS (Affinity Capture-MS), PMPCA (Affinity Capture-MS), PMPCB (Affinity Capture-MS), CHCHD2 (Affinity Capture-MS), POLDIP2 (Affinity Capture-MS), NDUFA10 (Affinity Capture-MS), ECH1 (Affinity Capture-MS)
ESM2 similar proteins: A0A2B7YDW3, A0A2Z4HPY4, A0A455LN86, A0A455LRW3, A0L2D7, A1CVK0, A1RE94, A1VPR5, A5EBX1, A8ZNR6, A9AWD5, B0U5U4, B0Y565, B0Y5B4, B2FJE7, B2I916, B3Y522, B4SMR2, B6K412, E4V6I8, M2XHU6, O48929, O49187, O50406, O87455, O94265, P05990, P55610, P9WEH1, Q00706, Q07YM7, Q09214, Q0AEJ6, Q0AHQ0, Q0HPW7, Q255B1, Q3AQA7, Q4H4F8, Q4WR16, Q55107
Diamond homologs: P37509, P37512, Q09214, Q6T393, Q80YT5, Q8TB22
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 52 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Respiratory electron transport | 8 | 19.0× | 2e-06 |
| Aerobic respiration and respiratory electron transport | 5 | 11.1× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
161 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 138 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3235 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:50548546:G:A | acceptor_gain | 1.0000 |
| 17:50548549:TCTA:T | acceptor_loss | 1.0000 |
| 17:50548550:CTAG:C | acceptor_loss | 1.0000 |
| 17:50548551:TA:T | acceptor_loss | 1.0000 |
| 17:50548615:TCAGG:T | donor_loss | 1.0000 |
| 17:50548616:CAGG:C | donor_loss | 1.0000 |
| 17:50548617:AGG:A | donor_loss | 1.0000 |
| 17:50548619:G:C | donor_loss | 1.0000 |
| 17:50548620:T:A | donor_loss | 1.0000 |
| 17:50548796:A:AG | acceptor_gain | 1.0000 |
| 17:50548796:AT:A | acceptor_gain | 1.0000 |
| 17:50548796:ATG:A | acceptor_gain | 1.0000 |
| 17:50548797:T:A | acceptor_gain | 1.0000 |
| 17:50548805:TTCAG:T | acceptor_loss | 1.0000 |
| 17:50548806:TCA:T | acceptor_loss | 1.0000 |
| 17:50548808:A:AG | acceptor_gain | 1.0000 |
| 17:50548808:AGTC:A | acceptor_gain | 1.0000 |
| 17:50548808:AGTCG:A | acceptor_gain | 1.0000 |
| 17:50548809:G:GA | acceptor_gain | 1.0000 |
| 17:50548809:GT:G | acceptor_gain | 1.0000 |
| 17:50548809:GTC:G | acceptor_gain | 1.0000 |
| 17:50548809:GTCG:G | acceptor_gain | 1.0000 |
| 17:50548809:GTCGG:G | acceptor_gain | 1.0000 |
| 17:50548830:T:A | acceptor_gain | 1.0000 |
| 17:50548961:GCAG:G | donor_gain | 1.0000 |
| 17:50548965:G:C | donor_loss | 1.0000 |
| 17:50548965:G:GG | donor_gain | 1.0000 |
| 17:50548966:T:G | donor_loss | 1.0000 |
| 17:50549037:C:CA | acceptor_gain | 1.0000 |
| 17:50549038:GCCA:G | acceptor_loss | 1.0000 |
AlphaMissense
5204 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:50548857:T:C | F121L | 0.998 |
| 17:50548859:C:A | F121L | 0.998 |
| 17:50548859:C:G | F121L | 0.998 |
| 17:50549079:T:A | W169R | 0.998 |
| 17:50549079:T:C | W169R | 0.998 |
| 17:50549083:T:C | L170P | 0.998 |
| 17:50550238:T:A | W326R | 0.998 |
| 17:50550238:T:C | W326R | 0.998 |
| 17:50550789:T:A | W403R | 0.998 |
| 17:50550789:T:C | W403R | 0.998 |
| 17:50551997:G:C | D576H | 0.998 |
| 17:50548452:T:A | W83R | 0.997 |
| 17:50548452:T:C | W83R | 0.997 |
| 17:50548561:T:A | W86R | 0.997 |
| 17:50548561:T:C | W86R | 0.997 |
| 17:50549075:T:A | N167K | 0.997 |
| 17:50549075:T:G | N167K | 0.997 |
| 17:50549155:T:C | F194S | 0.997 |
| 17:50549286:T:A | W205R | 0.997 |
| 17:50549286:T:C | W205R | 0.997 |
| 17:50552069:G:C | A600P | 0.997 |
| 17:50554256:G:C | D639H | 0.997 |
| 17:50548554:G:C | W83C | 0.996 |
| 17:50548554:G:T | W83C | 0.996 |
| 17:50548585:G:C | A94P | 0.996 |
| 17:50548586:C:A | A94D | 0.996 |
| 17:50548607:T:A | I101N | 0.996 |
| 17:50548613:T:A | L103H | 0.996 |
| 17:50548910:G:C | K138N | 0.996 |
| 17:50548910:G:T | K138N | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000060209 (17:50550508 T>C), RS1000443938 (17:50547841 T>C), RS1000473717 (17:50554178 A>C,G), RS1000475131 (17:50547570 C>T), RS1000697110 (17:50552736 T>C), RS1000725540 (17:50552728 A>G), RS1000761447 (17:50553973 G>A), RS1001217182 (17:50553035 C>T), RS1001316239 (17:50553884 C>T), RS1001378482 (17:50548700 T>G), RS1001532629 (17:50552020 C>A,T), RS1001600742 (17:50553641 G>A,T), RS1001670369 (17:50546999 A>C,G), RS1001826691 (17:50552343 T>A), RS1001983992 (17:50547192 C>A,T)
Disease associations
OMIM: gene MIM:613939 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006585_1912 | Blood protein levels | 4.000000e-81 |
| GCST010244_389 | Triglyceride levels | 2.000000e-10 |
| GCST90002405_384 | Reticulocyte count | 5.000000e-10 |
| GCST90020026_459 | Hip index | 2.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004530 | triglyceride measurement |
| EFO:0007986 | reticulocyte count |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
47 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | decreases expression | 3 |
| bisphenol A | increases expression, increases methylation | 2 |
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| Benzo(a)pyrene | increases expression, affects methylation | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| alpha-pinene | increases oxidation, increases abundance, affects cotreatment | 1 |
| glycidyl methacrylate | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| ochratoxin A | increases acetylation, increases expression | 1 |
| methacrylaldehyde | increases oxidation, increases abundance, affects cotreatment | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| entinostat | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Arsenic Trioxide | decreases response to substance | 1 |
| Acetaminophen | decreases expression | 1 |
| Acrolein | increases abundance, affects cotreatment, increases oxidation | 1 |
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation | 1 |
| Arbutin | decreases expression | 1 |
| Atrazine | increases expression | 1 |
| Cadmium | increases expression | 1 |
| Camptothecin | increases expression | 1 |
| Cisplatin | affects expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TQ14 | HAP1 SPATA20 (-) 1 | Cancer cell line | Male |
| CVCL_XT71 | HAP1 SPATA20 (-) 2 | Cancer cell line | Male |
| CVCL_XT72 | HAP1 SPATA20 (-) 3 | Cancer cell line | Male |
| CVCL_XT73 | HAP1 SPATA20 (-) 4 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.